ClinicalTrials.Veeva

Menu

Predicting Outcomes of Cardiac Surgery-associated Acute Kidney Injury Using Biomarkers At Initiation of RRT

Fudan University logo

Fudan University

Status

Enrolling

Conditions

Acute Kidney Injury

Treatments

Other: Renal Replacement Therapy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study was to verify the prognostic value of functional kidney biomarkers on survival and renal function recovery in cardiac surgery patients with acute kidney injury.

Full description

Cardiac surgery-associated acute kidney injury (CSA-AKI) is the second most common type of AKI after septic AKI and is associated with increased mortality and morbidity. Few biomarkers were validated as outcome-specific biomarkers in patients developing AKI after cardiac surgery at initiation of RRT. This study was designed to not only verify the prognostic value of functional kidney biomarkers on survival, but also predict it severity in order to optimize clinical decision making with respect to dialysis initiation and discontinuation.

Enrollment

1,200 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing cardiac surgery who required renal replacement therapy.

Exclusion criteria

  • History of End Stage Renal Disease or on Dialysis
  • prior kidney transplantation
  • patients with a DNR order or "do not escalate care" order

Trial contacts and locations

1

Loading...

Central trial contact

Guo-wei Tu, PhD; Ying Su, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems